Prior Chemotherapy for Leukemia May Hinder Effective CAR T-Cell Development – Journal of Clinical Pathways
Journal of Clinical Pathways |
Prior Chemotherapy for Leukemia May Hinder Effective CAR T-Cell Development
Journal of Clinical Pathways Younger patients who received certain chemotherapies for solid tumors or leukemia may not have T-cells capable of becoming effective chimeric antigen receptor (CAR) T-cells, according to a study to be presented at the American Association for Cancer … |
